You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FEPPA

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD, Neuroinflammation Trial in Stony Brook (Celecoxib 400 mg)

Recruiting
  • Major Depressive Disorder
  • Neuroinflammation
  • Celecoxib 400 mg
  • Stony Brook, New York
    Psychiatry Department at Stony Brook University
Oct 24, 2022

Microglia Activation in Asthma

Recruiting
  • Asthma
  • Whole lung antigen challenge (WLAC)
  • [18F]FEPPA
  • Madison, Wisconsin
    University of Wisconsin Madison
Jul 14, 2022

Neuroinflammation in COVID-19 and Depression

Recruiting
  • Major Depressive Episode
  • Covid19
  • [18F]FEPPA PET scan
  • [11C]SL25.1188 PET scan
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Apr 20, 2021

Frontotemporal Dementia Trial in London ((18F)-FEPPA)

Recruiting
  • Frontotemporal Dementia
  • (18F)-FEPPA
  • London, Ontario, Canada
    Parkwood Institute
Sep 2, 2020

Molecular Imaging of Brain Inflammation in Depressive Disorders

Completed
  • Depressive Disorder, Major
  • Positron-Emission Tomography
    • London, Ontario, Canada
      St Joseph's Hospital
    Apr 7, 2020

    Inflammation and Electroconvulsive Therapy

    Terminated
    • Major Depressive Disorder
      • Toronto, Ontario, Canada
        Centre for Addiction and Mental Health
      Feb 13, 2018

      MDD Trial in Toronto (Minocycline, Placebo, Celecoxib)

      Completed
      • Major Depressive Disorder
      • Toronto, Ontario, Canada
        Centre for Addiction and Mental Health
      May 22, 2019

      Alzheimer, Parkinson Disease, Multiple Sclerosis Trial in New Haven ([18F]-FEPPA)

      Completed
      • Alzheimer Disease
      • +2 more
      • New Haven, Connecticut
        Instiute for Neurodegenerative Disorders
      Feb 7, 2012